The global Metastatic Melanoma Diagnostic market is projected to grow from US$ 767 million in 2024 to US$ 1210.4 million by 2030, at a Compound Annual Growth Rate (CAGR) of 7.9% during the forecast period.

Metastatic Melanoma Diagnostic Market

Melanoma is one of the serious types of skin cancers that develops from pigment-containing cells called as melanocytes. Melanomas typically occur in the skin, but may rarely occur in the mouth, intestines, or eye. In women, they most commonly occur on the legs, while in men they are most common on the back. Moles, brown spots and growths on the skin are found to be the symptoms associated with the disease. When it spreads to other places in body, it's called metastatic, or advanced. Although in many cases metastatic melanoma can’t be cured, treatments and support can help people live longer and better. Doctors have therapies that have greatly increased survival rates. And researchers are working to find new medications that can do even more.

Market Analysis and Insights: Global Metastatic Melanoma Diagnostic Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Metastatic Melanoma Diagnostic market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Metastatic Melanoma Diagnostic, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Metastatic Melanoma Diagnostic, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Metastatic Melanoma Diagnostic revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Metastatic Melanoma Diagnostic market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Metastatic Melanoma Diagnostic revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Metastatic Melanoma Diagnostic Market Report

Report Metric	Details
Report Name	Metastatic Melanoma Diagnostic Market
Accounted market size in 2024	US$ 767 in million
Forecasted market size in 2030	US$ 1210.4 million
CAGR	7.9
Base Year	2024
Forecasted years	2024 - 2030
Segment by Type	BRAF Mutation Circulating Tumor Cells (CTCs) Immunohistochemistry Others
Segment by Application	Pathology Laboratories Hospitals Cancer Research Centres Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Myriad Genetics, Abbott Laboratories, Foundation Medicine, Pathway Genomics Corporation, Cancer Genetics, Castle Biosciences, NeoGenomics, Dermtech, Sysmex Inostics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Metastatic Melanoma Diagnostic in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Metastatic Melanoma Diagnostic companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Metastatic Melanoma Diagnostic revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Metastatic Melanoma Diagnostic Market growing?

Ans: The Metastatic Melanoma Diagnostic Market witnessing a CAGR of 7.9 during the forecast period 2024-2030.

What is the Metastatic Melanoma Diagnostic Market size in 2030?

Ans: The Metastatic Melanoma Diagnostic Market size in 2030 will be US$ 1210.4 million.

Who are the main players in the Metastatic Melanoma Diagnostic Market report?

Ans: The main players in the Metastatic Melanoma Diagnostic Market are Myriad Genetics, Abbott Laboratories, Foundation Medicine, Pathway Genomics Corporation, Cancer Genetics, Castle Biosciences, NeoGenomics, Dermtech, Sysmex Inostics

What are the Application segmentation covered in the Metastatic Melanoma Diagnostic Market report?

Ans: The Applications covered in the Metastatic Melanoma Diagnostic Market report are Pathology Laboratories, Hospitals, Cancer Research Centres, Others

What are the Type segmentation covered in the Metastatic Melanoma Diagnostic Market report?

Ans: The Types covered in the Metastatic Melanoma Diagnostic Market report are BRAF Mutation, Circulating Tumor Cells (CTCs), Immunohistochemistry, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Metastatic Melanoma Diagnostic Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 BRAF Mutation

1.2.3 Circulating Tumor Cells (CTCs)

1.2.4 Immunohistochemistry

1.2.5 Others

1.3 Market by Application

1.3.1 Global Metastatic Melanoma Diagnostic Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Pathology Laboratories

1.3.3 Hospitals

1.3.4 Cancer Research Centres

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Metastatic Melanoma Diagnostic Market Perspective (2019-2030)

2.2 Global Metastatic Melanoma Diagnostic Growth Trends by Region

2.2.1 Metastatic Melanoma Diagnostic Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Metastatic Melanoma Diagnostic Historic Market Size by Region (2019-2024)

2.2.3 Metastatic Melanoma Diagnostic Forecasted Market Size by Region (2025-2030)

2.3 Metastatic Melanoma Diagnostic Market Dynamics

2.3.1 Metastatic Melanoma Diagnostic Industry Trends

2.3.2 Metastatic Melanoma Diagnostic Market Drivers

2.3.3 Metastatic Melanoma Diagnostic Market Challenges

2.3.4 Metastatic Melanoma Diagnostic Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Metastatic Melanoma Diagnostic by Players

3.1.1 Global Metastatic Melanoma Diagnostic Revenue by Players (2019-2024)

3.1.2 Global Metastatic Melanoma Diagnostic Revenue Market Share by Players (2019-2024)

3.2 Global Metastatic Melanoma Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Metastatic Melanoma Diagnostic, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Metastatic Melanoma Diagnostic Market Concentration Ratio

3.4.1 Global Metastatic Melanoma Diagnostic Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Metastatic Melanoma Diagnostic Revenue in 2023

3.5 Global Key Players of Metastatic Melanoma Diagnostic Head office and Area Served

3.6 Global Key Players of Metastatic Melanoma Diagnostic, Product and Application

3.7 Global Key Players of Metastatic Melanoma Diagnostic, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Metastatic Melanoma Diagnostic Breakdown Data by Type

4.1 Global Metastatic Melanoma Diagnostic Historic Market Size by Type (2019-2024)

4.2 Global Metastatic Melanoma Diagnostic Forecasted Market Size by Type (2025-2030)

5 Metastatic Melanoma Diagnostic Breakdown Data by Application

5.1 Global Metastatic Melanoma Diagnostic Historic Market Size by Application (2019-2024)

5.2 Global Metastatic Melanoma Diagnostic Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Metastatic Melanoma Diagnostic Market Size (2019-2030)

6.2 North America Metastatic Melanoma Diagnostic Market Size by Type

6.2.1 North America Metastatic Melanoma Diagnostic Market Size by Type (2019-2024)

6.2.2 North America Metastatic Melanoma Diagnostic Market Size by Type (2025-2030)

6.2.3 North America Metastatic Melanoma Diagnostic Market Share by Type (2019-2030)

6.3 North America Metastatic Melanoma Diagnostic Market Size by Application

6.3.1 North America Metastatic Melanoma Diagnostic Market Size by Application (2019-2024)

6.3.2 North America Metastatic Melanoma Diagnostic Market Size by Application (2025-2030)

6.3.3 North America Metastatic Melanoma Diagnostic Market Share by Application (2019-2030)

6.4 North America Metastatic Melanoma Diagnostic Market Size by Country

6.4.1 North America Metastatic Melanoma Diagnostic Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Metastatic Melanoma Diagnostic Market Size by Country (2019-2024)

6.4.3 North America Metastatic Melanoma Diagnostic Market Size by Country (2025-2030)

6.4.4 United States

6.4.5 Canada

7 Europe

7.1 Europe Metastatic Melanoma Diagnostic Market Size (2019-2030)

7.2 Europe Metastatic Melanoma Diagnostic Market Size by Type

7.2.1 Europe Metastatic Melanoma Diagnostic Market Size by Type (2019-2024)

7.2.2 Europe Metastatic Melanoma Diagnostic Market Size by Type (2025-2030)

7.2.3 Europe Metastatic Melanoma Diagnostic Market Share by Type (2019-2030)

7.3 Europe Metastatic Melanoma Diagnostic Market Size by Application

7.3.1 Europe Metastatic Melanoma Diagnostic Market Size by Application (2019-2024)

7.3.2 Europe Metastatic Melanoma Diagnostic Market Size by Application (2025-2030)

7.3.3 Europe Metastatic Melanoma Diagnostic Market Share by Application (2019-2030)

7.4 Europe Metastatic Melanoma Diagnostic Market Size by Country

7.4.1 Europe Metastatic Melanoma Diagnostic Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Metastatic Melanoma Diagnostic Market Size by Country (2019-2024)

7.4.3 Europe Metastatic Melanoma Diagnostic Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Metastatic Melanoma Diagnostic Market Size (2019-2030)

8.2 China Metastatic Melanoma Diagnostic Market Size by Type

8.2.1 China Metastatic Melanoma Diagnostic Market Size by Type (2019-2024)

8.2.2 China Metastatic Melanoma Diagnostic Market Size by Type (2025-2030)

8.2.3 China Metastatic Melanoma Diagnostic Market Share by Type (2019-2030)

8.3 China Metastatic Melanoma Diagnostic Market Size by Application

8.3.1 China Metastatic Melanoma Diagnostic Market Size by Application (2019-2024)

8.3.2 China Metastatic Melanoma Diagnostic Market Size by Application (2025-2030)

8.3.3 China Metastatic Melanoma Diagnostic Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Metastatic Melanoma Diagnostic Market Size (2019-2030)

9.2 Asia Metastatic Melanoma Diagnostic Market Size by Type

9.2.1 Asia Metastatic Melanoma Diagnostic Market Size by Type (2019-2024)

9.2.2 Asia Metastatic Melanoma Diagnostic Market Size by Type (2025-2030)

9.2.3 Asia Metastatic Melanoma Diagnostic Market Share by Type (2019-2030)

9.3 Asia Metastatic Melanoma Diagnostic Market Size by Application

9.3.1 Asia Metastatic Melanoma Diagnostic Market Size by Application (2019-2024)

9.3.2 Asia Metastatic Melanoma Diagnostic Market Size by Application (2025-2030)

9.3.3 Asia Metastatic Melanoma Diagnostic Market Share by Application (2019-2030)

9.4 Asia Metastatic Melanoma Diagnostic Market Size by Region

9.4.1 Asia Metastatic Melanoma Diagnostic Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Metastatic Melanoma Diagnostic Market Size by Region (2019-2024)

9.4.3 Asia Metastatic Melanoma Diagnostic Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Metastatic Melanoma Diagnostic Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Metastatic Melanoma Diagnostic Market Size by Type

10.2.1 Middle East, Africa, and Latin America Metastatic Melanoma Diagnostic Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Metastatic Melanoma Diagnostic Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Metastatic Melanoma Diagnostic Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Metastatic Melanoma Diagnostic Market Size by Application

10.3.1 Middle East, Africa, and Latin America Metastatic Melanoma Diagnostic Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Metastatic Melanoma Diagnostic Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Metastatic Melanoma Diagnostic Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Metastatic Melanoma Diagnostic Market Size by Country

10.4.1 Middle East, Africa, and Latin America Metastatic Melanoma Diagnostic Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Metastatic Melanoma Diagnostic Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Metastatic Melanoma Diagnostic Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Myriad Genetics

11.1.1 Myriad Genetics Company Details

11.1.2 Myriad Genetics Business Overview

11.1.3 Myriad Genetics Metastatic Melanoma Diagnostic Introduction

11.1.4 Myriad Genetics Revenue in Metastatic Melanoma Diagnostic Business (2019-2024)

11.1.5 Myriad Genetics Recent Developments

11.2 Abbott Laboratories

11.2.1 Abbott Laboratories Company Details

11.2.2 Abbott Laboratories Business Overview

11.2.3 Abbott Laboratories Metastatic Melanoma Diagnostic Introduction

11.2.4 Abbott Laboratories Revenue in Metastatic Melanoma Diagnostic Business (2019-2024)

11.2.5 Abbott Laboratories Recent Developments

11.3 Foundation Medicine

11.3.1 Foundation Medicine Company Details

11.3.2 Foundation Medicine Business Overview

11.3.3 Foundation Medicine Metastatic Melanoma Diagnostic Introduction

11.3.4 Foundation Medicine Revenue in Metastatic Melanoma Diagnostic Business (2019-2024)

11.3.5 Foundation Medicine Recent Developments

11.4 Pathway Genomics Corporation

11.4.1 Pathway Genomics Corporation Company Details

11.4.2 Pathway Genomics Corporation Business Overview

11.4.3 Pathway Genomics Corporation Metastatic Melanoma Diagnostic Introduction

11.4.4 Pathway Genomics Corporation Revenue in Metastatic Melanoma Diagnostic Business (2019-2024)

11.4.5 Pathway Genomics Corporation Recent Developments

11.5 Cancer Genetics

11.5.1 Cancer Genetics Company Details

11.5.2 Cancer Genetics Business Overview

11.5.3 Cancer Genetics Metastatic Melanoma Diagnostic Introduction

11.5.4 Cancer Genetics Revenue in Metastatic Melanoma Diagnostic Business (2019-2024)

11.5.5 Cancer Genetics Recent Developments

11.6 Castle Biosciences

11.6.1 Castle Biosciences Company Details

11.6.2 Castle Biosciences Business Overview

11.6.3 Castle Biosciences Metastatic Melanoma Diagnostic Introduction

11.6.4 Castle Biosciences Revenue in Metastatic Melanoma Diagnostic Business (2019-2024)

11.6.5 Castle Biosciences Recent Developments

11.7 NeoGenomics

11.7.1 NeoGenomics Company Details

11.7.2 NeoGenomics Business Overview

11.7.3 NeoGenomics Metastatic Melanoma Diagnostic Introduction

11.7.4 NeoGenomics Revenue in Metastatic Melanoma Diagnostic Business (2019-2024)

11.7.5 NeoGenomics Recent Developments

11.8 Dermtech

11.8.1 Dermtech Company Details

11.8.2 Dermtech Business Overview

11.8.3 Dermtech Metastatic Melanoma Diagnostic Introduction

11.8.4 Dermtech Revenue in Metastatic Melanoma Diagnostic Business (2019-2024)

11.8.5 Dermtech Recent Developments

11.9 Sysmex Inostics

11.9.1 Sysmex Inostics Company Details

11.9.2 Sysmex Inostics Business Overview

11.9.3 Sysmex Inostics Metastatic Melanoma Diagnostic Introduction

11.9.4 Sysmex Inostics Revenue in Metastatic Melanoma Diagnostic Business (2019-2024)

11.9.5 Sysmex Inostics Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Myriad Genetics

Abbott Laboratories

Foundation Medicine

Pathway Genomics Corporation

List of Tables

Table 1. Global Metastatic Melanoma Diagnostic Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of BRAF Mutation

Table 3. Key Players of Circulating Tumor Cells (CTCs)

Table 4. Key Players of Immunohistochemistry

Table 5. Key Players of Others

Table 6. Global Metastatic Melanoma Diagnostic Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 7. Global Metastatic Melanoma Diagnostic Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Metastatic Melanoma Diagnostic Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Metastatic Melanoma Diagnostic Market Share by Region (2019-2024)

Table 10. Global Metastatic Melanoma Diagnostic Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Metastatic Melanoma Diagnostic Market Share by Region (2025-2030)

Table 12. Metastatic Melanoma Diagnostic Market Trends

Table 13. Metastatic Melanoma Diagnostic Market Drivers

Table 14. Metastatic Melanoma Diagnostic Market Challenges

Table 15. Metastatic Melanoma Diagnostic Market Restraints

Table 16. Global Metastatic Melanoma Diagnostic Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Metastatic Melanoma Diagnostic Revenue Share by Players (2019-2024)

Table 18. Global Top Metastatic Melanoma Diagnostic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metastatic Melanoma Diagnostic as of 2023)

Table 19. Global Metastatic Melanoma Diagnostic Industry Ranking 2022 VS 2023 VS 2024

Table 20. Global 5 Largest Players Market Share by Metastatic Melanoma Diagnostic Revenue (CR5 and HHI) & (2019-2024)

Table 21. Global Key Players of Metastatic Melanoma Diagnostic, Headquarters and Area Served

Table 22. Global Key Players of Metastatic Melanoma Diagnostic, Product and Application

Table 23. Global Key Players of Metastatic Melanoma Diagnostic, Product and Application

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Metastatic Melanoma Diagnostic Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Metastatic Melanoma Diagnostic Revenue Market Share by Type (2019-2024)

Table 27. Global Metastatic Melanoma Diagnostic Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Metastatic Melanoma Diagnostic Revenue Market Share by Type (2025-2030)

Table 29. Global Metastatic Melanoma Diagnostic Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Metastatic Melanoma Diagnostic Revenue Share by Application (2019-2024)

Table 31. Global Metastatic Melanoma Diagnostic Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Metastatic Melanoma Diagnostic Revenue Share by Application (2025-2030)

Table 33. North America Metastatic Melanoma Diagnostic Market Size by Type (2019-2024) & (US$ Million)

Table 34. North America Metastatic Melanoma Diagnostic Market Size by Type (2025-2030) & (US$ Million)

Table 35. North America Metastatic Melanoma Diagnostic Market Size by Application (2019-2024) & (US$ Million)

Table 36. North America Metastatic Melanoma Diagnostic Market Size by Application (2025-2030) & (US$ Million)

Table 37. North America Metastatic Melanoma Diagnostic Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. North America Metastatic Melanoma Diagnostic Market Size by Country (2019-2024) & (US$ Million)

Table 39. North America Metastatic Melanoma Diagnostic Market Size by Country (2025-2030) & (US$ Million)

Table 40. Europe Metastatic Melanoma Diagnostic Market Size by Type (2019-2024) & (US$ Million)

Table 41. Europe Metastatic Melanoma Diagnostic Market Size by Type (2025-2030) & (US$ Million)

Table 42. Europe Metastatic Melanoma Diagnostic Market Size by Application (2019-2024) & (US$ Million)

Table 43. Europe Metastatic Melanoma Diagnostic Market Size by Application (2025-2030) & (US$ Million)

Table 44. Europe Metastatic Melanoma Diagnostic Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Europe Metastatic Melanoma Diagnostic Market Size by Country (2019-2024) & (US$ Million)

Table 46. Europe Metastatic Melanoma Diagnostic Market Size by Country (2025-2030) & (US$ Million)

Table 47. China Metastatic Melanoma Diagnostic Market Size by Type (2019-2024) & (US$ Million)

Table 48. China Metastatic Melanoma Diagnostic Market Size by Type (2025-2030) & (US$ Million)

Table 49. China Metastatic Melanoma Diagnostic Market Size by Application (2019-2024) & (US$ Million)

Table 50. China Metastatic Melanoma Diagnostic Market Size by Application (2025-2030) & (US$ Million)

Table 51. Asia Metastatic Melanoma Diagnostic Market Size by Type (2019-2024) & (US$ Million)

Table 52. Asia Metastatic Melanoma Diagnostic Market Size by Type (2025-2030) & (US$ Million)

Table 53. Asia Metastatic Melanoma Diagnostic Market Size by Application (2019-2024) & (US$ Million)

Table 54. Asia Metastatic Melanoma Diagnostic Market Size by Application (2025-2030) & (US$ Million)

Table 55. Asia Metastatic Melanoma Diagnostic Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 56. Asia Metastatic Melanoma Diagnostic Market Size by Region (2019-2024) & (US$ Million)

Table 57. Asia Metastatic Melanoma Diagnostic Market Size by Region (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Metastatic Melanoma Diagnostic Market Size by Type (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Metastatic Melanoma Diagnostic Market Size by Type (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Metastatic Melanoma Diagnostic Market Size by Application (2019-2024) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Metastatic Melanoma Diagnostic Market Size by Application (2025-2030) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Metastatic Melanoma Diagnostic Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 63. Middle East, Africa, and Latin America Metastatic Melanoma Diagnostic Market Size by Country (2019-2024) & (US$ Million)

Table 64. Middle East, Africa, and Latin America Metastatic Melanoma Diagnostic Market Size by Country (2025-2030) & (US$ Million)

Table 65. Myriad Genetics Company Details

Table 66. Myriad Genetics Business Overview

Table 67. Myriad Genetics Metastatic Melanoma Diagnostic Product

Table 68. Myriad Genetics Revenue in Metastatic Melanoma Diagnostic Business (2019-2024) & (US$ Million)

Table 69. Myriad Genetics Recent Developments

Table 70. Abbott Laboratories Company Details

Table 71. Abbott Laboratories Business Overview

Table 72. Abbott Laboratories Metastatic Melanoma Diagnostic Product

Table 73. Abbott Laboratories Revenue in Metastatic Melanoma Diagnostic Business (2019-2024) & (US$ Million)

Table 74. Abbott Laboratories Recent Developments

Table 75. Foundation Medicine Company Details

Table 76. Foundation Medicine Business Overview

Table 77. Foundation Medicine Metastatic Melanoma Diagnostic Product

Table 78. Foundation Medicine Revenue in Metastatic Melanoma Diagnostic Business (2019-2024) & (US$ Million)

Table 79. Foundation Medicine Recent Developments

Table 80. Pathway Genomics Corporation Company Details

Table 81. Pathway Genomics Corporation Business Overview

Table 82. Pathway Genomics Corporation Metastatic Melanoma Diagnostic Product

Table 83. Pathway Genomics Corporation Revenue in Metastatic Melanoma Diagnostic Business (2019-2024) & (US$ Million)

Table 84. Pathway Genomics Corporation Recent Developments

Table 85. Cancer Genetics Company Details

Table 86. Cancer Genetics Business Overview

Table 87. Cancer Genetics Metastatic Melanoma Diagnostic Product

Table 88. Cancer Genetics Revenue in Metastatic Melanoma Diagnostic Business (2019-2024) & (US$ Million)

Table 89. Cancer Genetics Recent Developments

Table 90. Castle Biosciences Company Details

Table 91. Castle Biosciences Business Overview

Table 92. Castle Biosciences Metastatic Melanoma Diagnostic Product

Table 93. Castle Biosciences Revenue in Metastatic Melanoma Diagnostic Business (2019-2024) & (US$ Million)

Table 94. Castle Biosciences Recent Developments

Table 95. NeoGenomics Company Details

Table 96. NeoGenomics Business Overview

Table 97. NeoGenomics Metastatic Melanoma Diagnostic Product

Table 98. NeoGenomics Revenue in Metastatic Melanoma Diagnostic Business (2019-2024) & (US$ Million)

Table 99. NeoGenomics Recent Developments

Table 100. Dermtech Company Details

Table 101. Dermtech Business Overview

Table 102. Dermtech Metastatic Melanoma Diagnostic Product

Table 103. Dermtech Revenue in Metastatic Melanoma Diagnostic Business (2019-2024) & (US$ Million)

Table 104. Dermtech Recent Developments

Table 105. Sysmex Inostics Company Details

Table 106. Sysmex Inostics Business Overview

Table 107. Sysmex Inostics Metastatic Melanoma Diagnostic Product

Table 108. Sysmex Inostics Revenue in Metastatic Melanoma Diagnostic Business (2019-2024) & (US$ Million)

Table 109. Sysmex Inostics Recent Developments

Table 110. Research Programs/Design for This Report

Table 111. Key Data Information from Secondary Sources

Table 112. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Metastatic Melanoma Diagnostic Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Metastatic Melanoma Diagnostic Market Share by Type: 2023 VS 2030

Figure 3. BRAF Mutation Features

Figure 4. Circulating Tumor Cells (CTCs) Features

Figure 5. Immunohistochemistry Features

Figure 6. Others Features

Figure 7. Global Metastatic Melanoma Diagnostic Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 8. Global Metastatic Melanoma Diagnostic Market Share by Application: 2023 VS 2030

Figure 9. Pathology Laboratories Case Studies

Figure 10. Hospitals Case Studies

Figure 11. Cancer Research Centres Case Studies

Figure 12. Others Case Studies

Figure 13. Metastatic Melanoma Diagnostic Report Years Considered

Figure 14. Global Metastatic Melanoma Diagnostic Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 15. Global Metastatic Melanoma Diagnostic Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Metastatic Melanoma Diagnostic Market Share by Region: 2023 VS 2030

Figure 17. Global Metastatic Melanoma Diagnostic Market Share by Players in 2023

Figure 18. Global Top Metastatic Melanoma Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metastatic Melanoma Diagnostic as of 2023)

Figure 19. The Top 10 and 5 Players Market Share by Metastatic Melanoma Diagnostic Revenue in 2023

Figure 20. North America Metastatic Melanoma Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. North America Metastatic Melanoma Diagnostic Market Share by Type (2019-2030)

Figure 22. North America Metastatic Melanoma Diagnostic Market Share by Application (2019-2030)

Figure 23. North America Metastatic Melanoma Diagnostic Market Share by Country (2019-2030)

Figure 24. United States Metastatic Melanoma Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Canada Metastatic Melanoma Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Europe Metastatic Melanoma Diagnostic Market Size YoY (2019-2030) & (US$ Million)

Figure 27. Europe Metastatic Melanoma Diagnostic Market Share by Type (2019-2030)

Figure 28. Europe Metastatic Melanoma Diagnostic Market Share by Application (2019-2030)

Figure 29. Europe Metastatic Melanoma Diagnostic Market Share by Country (2019-2030)

Figure 30. Germany Metastatic Melanoma Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. France Metastatic Melanoma Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. U.K. Metastatic Melanoma Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Italy Metastatic Melanoma Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Russia Metastatic Melanoma Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Nordic Countries Metastatic Melanoma Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. China Metastatic Melanoma Diagnostic Market Size YoY (2019-2030) & (US$ Million)

Figure 37. China Metastatic Melanoma Diagnostic Market Share by Type (2019-2030)

Figure 38. China Metastatic Melanoma Diagnostic Market Share by Application (2019-2030)

Figure 39. Asia Metastatic Melanoma Diagnostic Market Size YoY (2019-2030) & (US$ Million)

Figure 40. Asia Metastatic Melanoma Diagnostic Market Share by Type (2019-2030)

Figure 41. Asia Metastatic Melanoma Diagnostic Market Share by Application (2019-2030)

Figure 42. Asia Metastatic Melanoma Diagnostic Market Share by Region (2019-2030)

Figure 43. Japan Metastatic Melanoma Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. South Korea Metastatic Melanoma Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. China Taiwan Metastatic Melanoma Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Southeast Asia Metastatic Melanoma Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. India Metastatic Melanoma Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Australia Metastatic Melanoma Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Middle East, Africa, and Latin America Metastatic Melanoma Diagnostic Market Size YoY (2019-2030) & (US$ Million)

Figure 50. Middle East, Africa, and Latin America Metastatic Melanoma Diagnostic Market Share by Type (2019-2030)

Figure 51. Middle East, Africa, and Latin America Metastatic Melanoma Diagnostic Market Share by Application (2019-2030)

Figure 52. Middle East, Africa, and Latin America Metastatic Melanoma Diagnostic Market Share by Country (2019-2030)

Figure 53. Brazil Metastatic Melanoma Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Mexico Metastatic Melanoma Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Turkey Metastatic Melanoma Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Saudi Arabia Metastatic Melanoma Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. Israel Metastatic Melanoma Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. GCC Countries Metastatic Melanoma Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 59. Myriad Genetics Revenue Growth Rate in Metastatic Melanoma Diagnostic Business (2019-2024)

Figure 60. Abbott Laboratories Revenue Growth Rate in Metastatic Melanoma Diagnostic Business (2019-2024)

Figure 61. Foundation Medicine Revenue Growth Rate in Metastatic Melanoma Diagnostic Business (2019-2024)

Figure 62. Pathway Genomics Corporation Revenue Growth Rate in Metastatic Melanoma Diagnostic Business (2019-2024)

Figure 63. Cancer Genetics Revenue Growth Rate in Metastatic Melanoma Diagnostic Business (2019-2024)

Figure 64. Castle Biosciences Revenue Growth Rate in Metastatic Melanoma Diagnostic Business (2019-2024)

Figure 65. NeoGenomics Revenue Growth Rate in Metastatic Melanoma Diagnostic Business (2019-2024)

Figure 66. Dermtech Revenue Growth Rate in Metastatic Melanoma Diagnostic Business (2019-2024)

Figure 67. Sysmex Inostics Revenue Growth Rate in Metastatic Melanoma Diagnostic Business (2019-2024)

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions